Q1 2020

Source filing unavailable

Q1 2020 · —

Revenue—

Net Income

-$31.95K

N/M vs Q1 2019

EPS Diluted

$0.00

N/M vs Q1 2019

Gross Profit$253,423—

Operating Income-$32,082N/M

Operating Cash Flowderived$205,895N/M

Same quarter

Metric	Q1 2020	Q1 2019	Q1 2018	Q1 2017
Revenue	—	$0.00	$0.00	$0.00
Net Income	-$31.95K	-$34.00K	-$45.00K	-$43.00K
EPS Diluted	$0.00	-$0.03	-$0.04	-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR